A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

Clinical trial NCT03096912 · UNKNOWN

Trial details

NCT number: NCT03096912
Sponsor: Assaf-Harofeh Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Liposarcomas, Dedifferentiated Liposarcoma - Well Differentiated Liposarcoma; Mixed Type Soft-Tissue Sarcoma

Start date: 2016-07-01
Primary completion: 2019-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.